These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

557 related articles for article (PubMed ID: 30833320)

  • 1. Multimorbidity of cardiometabolic diseases: prevalence and risk for mortality from one million Chinese adults in a longitudinal cohort study.
    Zhang D; Tang X; Shen P; Si Y; Liu X; Xu Z; Wu J; Zhang J; Lu P; Lin H; Gao P
    BMJ Open; 2019 Mar; 9(3):e024476. PubMed ID: 30833320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations of Cardiometabolic Multimorbidity With All-Cause and Coronary Heart Disease Mortality Among Black Adults in the Jackson Heart Study.
    Joseph JJ; Rajwani A; Roper D; Zhao S; Kline D; Odei J; Brock G; Echouffo-Tcheugui JB; Kalyani RR; Bertoni AG; Effoe VS; Sims M; Wu WC; Wand GS; Golden SH
    JAMA Netw Open; 2022 Oct; 5(10):e2238361. PubMed ID: 36282500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consultation rates in people with type 2 diabetes with and without vascular complications: a retrospective analysis of 141,328 adults in England.
    Abner S; Gillies CL; Shabnam S; Zaccardi F; Seidu S; Davies MJ; Adeyemi T; Khunti K; Webb DR
    Cardiovasc Diabetol; 2022 Jan; 21(1):8. PubMed ID: 35012531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age, sex, residence, and region-specific differences in prevalence and patterns of multimorbidity among older Chinese: evidence from Chinese Longitudinal Healthy Longevity Survey.
    Han S; Mo G; Gao T; Sun Q; Liu H; Zhang M
    BMC Public Health; 2022 Jun; 22(1):1116. PubMed ID: 35658851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health System Performance for Multimorbid Cardiometabolic Disease in India: A Population-Based Cross-Sectional Study.
    Geldsetzer P; De Neve JW; Mohan V; Prabhakaran D; Roy A; Tandon N; Davies JI; Vollmer S; Bärnighausen T; Prenissl J
    Glob Heart; 2022; 17(1):7. PubMed ID: 35174048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association Between Residential Greenness, Cardiometabolic Disorders, and Cardiovascular Disease Among Adults in China.
    Yang BY; Hu LW; Jalaludin B; Knibbs LD; Markevych I; Heinrich J; Bloom MS; Morawska L; Lin S; Jalava P; Roponen M; Gao M; Chen DH; Zhou Y; Yu HY; Liu RQ; Zeng XW; Zeeshan M; Guo Y; Yu Y; Dong GH
    JAMA Netw Open; 2020 Sep; 3(9):e2017507. PubMed ID: 32955574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of cardiometabolic index and sarcopenia with cardiometabolic multimorbidity in middle-aged and older adult: a prospective study.
    He L; Lin C; Tu Y; Yang Y; Lin M; Tu H; Li J
    Front Endocrinol (Lausanne); 2024; 15():1387374. PubMed ID: 38863933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temporal change in multimorbidity prevalence, clustering patterns, and the association with mortality: findings from the China Kadoorie Biobank study in Jiangsu Province.
    Yu H; Tao R; Zhou J; Su J; Lu Y; Hua Y; Jin J; Pei P; Yu C; Sun D; Chen Z; Li L; Lv J
    Front Public Health; 2024; 12():1389635. PubMed ID: 38699413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of multimorbidity of non-communicable diseases with mortality: a 10-year prospective study of 0.5 million Chinese adults.
    Zou S; Wang Z; Bhura M; Tang K
    Public Health; 2022 Apr; 205():63-71. PubMed ID: 35240390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association between Chinese visceral adiposity index and cardiometabolic multimorbidity among Chinese middle-aged and older adults: a national cohort study.
    Ye X; Zhang G; Han C; Wang P; Lu J; Zhang M
    Front Endocrinol (Lausanne); 2024; 15():1381949. PubMed ID: 38601202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Individual and Combined Cardiometabolic Morbidities and the Subsequent Risk of Cardiovascular Events in Chinese Adults.
    Wang J; Wang Z; Guo F; Zhang Y; Ji H; Chen G; Wan Q; Yan L; Wang G; Qin Y; Luo Z; Tang X; Huo Y; Hu R; Ye Z; Shi L; Gao Z; Su Q; Mu Y; Zhao J; Chen L; Zeng T; Yu X; Li Q; Shen F; Chen L; Zhang Y; Wang Y; Deng H; Liu C; Wu S; Yang T; Li M; Xu Y; Xu M; Zhao Z; Wang T; Lu J; Bi Y; Wang W; Ning G; Zhao Y; Qin G
    J Clin Endocrinol Metab; 2022 Jan; 107(1):e84-e94. PubMed ID: 34427675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of comorbid depression and obesity with cardiometabolic multimorbidity among middle-aged and older Chinese adults: A cohort study.
    Qin K; Bai S; Chen W; Li J; Guo VY
    Arch Gerontol Geriatr; 2023 Apr; 107():104912. PubMed ID: 36565606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical, socioeconomic, and behavioural factors at age 50 years and risk of cardiometabolic multimorbidity and mortality: A cohort study.
    Singh-Manoux A; Fayosse A; Sabia S; Tabak A; Shipley M; Dugravot A; Kivimäki M
    PLoS Med; 2018 May; 15(5):e1002571. PubMed ID: 29782486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiometabolic multimorbidity, lifestyle behaviours, and cognitive function: a multicohort study.
    Jin Y; Liang J; Hong C; Liang R; Luo Y
    Lancet Healthy Longev; 2023 Jun; 4(6):e265-e273. PubMed ID: 37150183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-occurrence of cardiometabolic diseases and frailty in older Chinese adults in the Beijing Longitudinal Study of Ageing.
    Tang Z; Wang C; Song X; Shi J; Mitnitski A; Fang X; Yu P; Rockwood K
    Age Ageing; 2013 May; 42(3):346-51. PubMed ID: 23462693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations of serum lead, cadmium, and mercury concentrations with all-cause and cause-specific mortality among individuals with cardiometabolic multimorbidity.
    Zhang A; Wei P; Ding L; Zhang H; Jiang Z; Mi L; Yu F; Tang M
    Ecotoxicol Environ Saf; 2024 Jul; 280():116556. PubMed ID: 38852466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of cardiometabolic multimorbidity and the risk of depressive symptoms in a longitudinal cohort of middle-aged and older Chinese.
    Huang ZT; Luo Y; Han L; Wang K; Yao SS; Su HX; Chen S; Cao GY; De Fries CM; Chen ZS; Xu HW; Hu YH; Xu B
    J Affect Disord; 2022 Mar; 301():1-7. PubMed ID: 34999125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leisure-time physical activity and life expectancy in people with cardiometabolic multimorbidity and depression.
    Chudasama YV; Zaccardi F; Gillies CL; Dhalwani NN; Yates T; Rowlands AV; Davies MJ; Khunti K
    J Intern Med; 2020 Jan; 287(1):87-99. PubMed ID: 31602698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The burden of cardiovascular morbidity in a European Mediterranean population with multimorbidity: a cross-sectional study.
    Violán C; Bejarano-Rivera N; Foguet-Boreu Q; Roso Llorach A; Pons-Vigués M; Martin Mateo M; Pujol-Ribera E
    BMC Fam Pract; 2016 Nov; 17(1):150. PubMed ID: 27809772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and correlates of cardiometabolic multimorbidity among hypertensive individuals: a cross-sectional study in rural South Asia-Bangladesh, Pakistan and Sri Lanka.
    Feng L; Jehan I; de Silva HA; Naheed A; Farazdaq H; Hirani S; Kasturiratne A; Ranasinha CD; Islam MT; Siddiquee AT; Jafar TH
    BMJ Open; 2019 Sep; 9(9):e030584. PubMed ID: 31488490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.